Home LiteratureArticle Details
PMID: 9294203 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.

Posavad CM, Koelle DM, Shaughnessy MF, Corey L

Abstract

The specific mechanisms underlying the varied susceptibility of HIV-infected (HIV+) individuals to opportunistic infections (OI) are still incompletely understood. One hypothesis is that quantitative differences in specific T cell responses to a colonizing organism determine the development of an AIDS-defining OI. We evaluated this hypothesis for herpes simplex virus (HSV) infection, a common OI in HIV+ patients. Using limiting dilution analyses, the frequency of HSV-specific CD8+ cytotoxic T lymphocyte precursors (pCTL) and proliferative precursors were quantitated in peripheral blood mononuclear cells from 20 patients coinfected with HIV and HSV-2. The frequency of HSV-specific CD8+ pCTL in HSV+HIV+ individuals was significantly lower than in HSV+HIV- individuals (1 in 77,000 vs. 1 in 6,000, P = .0005) and was not different than in HSV-HIV- individuals (1 in 100,000, P = .24). HIV+ patients who suffered more severe genital herpes recurrences had significantly lower HSV-specific CD8+ pCTL frequencies than those patients with mild recurrences (1 in 170,000 vs. 1 in 26,000, P = .03). In contrast, no significant difference was seen in proliferative precursor frequencies between those patients with mild vs. severe genital herpes (1 in 3,800 vs. 1 in 6,600, P > .5). Quantitative differences in pCTL frequency to HSV appear to be the most important host factor influencing the frequency and severity of HSV reactivation in HIV+ patients. Studies to reconstitute such immunity, especially in people with acyclovir-resistant HSV, appear warranted.

MeSH Terms
CD8-Positive T-Lymphocytes/immunology Cell Line, Transformed Cross-Sectional Studies Cytotoxicity, Immunologic Female HIV Infections/complications,immunology Herpes Genitalis/complications,immunology,physiopathology Herpesvirus 2, Human/immunology Humans Male
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Posavad C M
Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
Koelle D M
Shaughnessy M F
Corey L
References (30)
30 references, click to expand
  1. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
    J Immunol. 1988 May 15;140(10):3419-25 PMID: 2452188
  2. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2.
    J Infect Dis. 1996 Nov;174(5):899-906 PMID: 8896488
  3. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Clin Exp Immunol. 1989 Sep;77(3):384-90 PMID: 2553308
  4. Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals.
    J Clin Microbiol. 1989 Oct;27(10):2316-23 PMID: 2555391
  5. Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
    Ann Intern Med. 1990 Mar 15;112(6):416-22 PMID: 2155570
  6. Lymphoproliferative responses in recrudescent orofacial herpetic infections.
    J R Soc Med. 1990 May;83(5):308-11 PMID: 2166159
  7. Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated cytotoxicity.
    J Med Virol. 1990 Jul;31(3):183-9 PMID: 2167943
  8. Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection.
    Infection. 1991 May-Jun;19(3):140-5 PMID: 1653770
  9. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes.
    Virology. 1992 Feb;186(2):788-91 PMID: 1310199
  10. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    J Virol. 1992 Mar;66(3):1622-34 PMID: 1310769
  11. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.
    J Virol. 1992 Nov;66(11):6264-72 PMID: 1328666
  12. Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    J Infect Dis. 1994 Jan;169(1):193-6 PMID: 8277181
  13. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
    J Virol. 1994 May;68(5):2803-10 PMID: 7512152
  14. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.
    J Infect Dis. 1994 May;169(5):956-61 PMID: 8169426
  15. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.
    J Infect Dis. 1994 Jul;170(1):68-75 PMID: 8014522
  16. Epidemiology of genital herpes.
    J Int Med Res. 1994;22 Suppl 1:14A-23A PMID: 8063020
  17. Sexually transmitted diseases in HIV-infected persons.
    Infect Dis Clin North Am. 1994 Jun;8(2):439-48 PMID: 8089470
  18. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    N Engl J Med. 1995 Oct 19;333(16):1038-44 PMID: 7675046
  19. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women.
    Ann Intern Med. 1995 Dec 1;123(11):845-7 PMID: 7486467
  20. T cell blastogenic responses to Toxoplasma gondii trophozoites among HIV-infected patients.
    AIDS Res Hum Retroviruses. 1995 Jun;11(6):741-6 PMID: 7576934
  21. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
    J Infect Dis. 1996 Jan;173(1):7-17 PMID: 8537685
  22. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.
    Nat Med. 1996 May;2(5):551-5 PMID: 8616714
  23. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.
    J Immunol. 1981 Apr;126(4):1614-9 PMID: 7009746
  24. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    J Immunol. 1984 Nov;133(5):2736-42 PMID: 6207243
  25. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Cancer Res. 1985 Jan;45(1):406-10 PMID: 2578099
  26. Antibody levels for cytomegalovirus, herpes simplex virus, and rubella in patients with acquired immune deficiency syndrome.
    J Clin Microbiol. 1986 Feb;23(2):318-21 PMID: 3009534
  27. Specific stimulation of lymphocytes from patients with AIDS by herpes simplex virus antigens.
    Immunology. 1987 Feb;60(2):275-80 PMID: 3028941
  28. Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.
    J Clin Invest. 1996 Aug 1;98(3):731-40 PMID: 8698865
  29. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes.
    J Virol. 1996 Nov;70(11):8165-8 PMID: 8892947
  30. The association between genital ulcer disease and acquisition of HIV infection in homosexual men.
    JAMA. 1988 Sep 9;260(10):1429-33 PMID: 3404600
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-09-16
Pages
10289-94
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC23355
Subset
IM
Grants
NIAID NIH HHS · P01 AI034616 · United States
NIAID NIH HHS · P01 AI030731 · United States
NCI NIH HHS · CA70017 · United States
NIAID NIH HHS · AI30731 · United States
NIAID NIH HHS · AI34616 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com